Avity Investment Management Inc. Acquires 24,236 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Avity Investment Management Inc. grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 6.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 379,078 shares of the company's stock after buying an additional 24,236 shares during the period. GE HealthCare Technologies makes up about 2.3% of Avity Investment Management Inc.'s holdings, making the stock its 21st biggest holding. Avity Investment Management Inc. owned 0.08% of GE HealthCare Technologies worth $29,636,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. LGT Financial Advisors LLC raised its stake in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 251 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at $26,000. Capital Performance Advisors LLP purchased a new position in GE HealthCare Technologies in the 3rd quarter worth $26,000. Darwin Wealth Management LLC bought a new stake in GE HealthCare Technologies in the third quarter worth $31,000. Finally, Continuum Advisory LLC boosted its position in GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after buying an additional 168 shares during the period. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Down 0.6 %

Shares of GE HealthCare Technologies stock traded down $0.47 on Wednesday, reaching $83.66. The company's stock had a trading volume of 4,148,593 shares, compared to its average volume of 3,399,888. GE HealthCare Technologies Inc. has a 52 week low of $71.31 and a 52 week high of $94.55. The firm's fifty day simple moving average is $82.13 and its two-hundred day simple moving average is $84.27. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The company has a market capitalization of $38.22 billion, a price-to-earnings ratio of 22.98, a P/E/G ratio of 2.90 and a beta of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. The company had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. GE HealthCare Technologies's revenue for the quarter was up .9% on a year-over-year basis. During the same period last year, the company earned $0.99 EPS. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. GE HealthCare Technologies's dividend payout ratio is 3.85%.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.27% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on GEHC shares. Stifel Nicolaus increased their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a report on Monday, September 30th. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a research note on Thursday, October 31st. BTIG Research raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price on the stock in a research note on Wednesday, September 18th. UBS Group lowered shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and lowered their price target for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and a consensus target price of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.